...
首页> 外文期刊>Cell transplantation >Human Multipotent Mesenchymal Stromal Cells From Fetal Lung Expressing Pluripotent Markers and Differentiating Into Cell Types of Three Germ Layers
【24h】

Human Multipotent Mesenchymal Stromal Cells From Fetal Lung Expressing Pluripotent Markers and Differentiating Into Cell Types of Three Germ Layers

机译:来自胎儿肺部表达多能标记物的人类多能的间充质细胞并分化为细胞类型的三种胚层

获取原文
获取原文并翻译 | 示例

摘要

Multipotent mesenchymal stromal cells (MSCs) are a promising cell type for cell transplantation; however, their utilization remains limited until the availability of adequate alternative sources of MSCs and the thorough understanding of the biology of MSCs isolated from various sources are realized. Fetal lung has been identified as a rich source of MSCs. To explore the therapeutic potential of passaged fetal lung MSCs (FLMSCs), the present study evaluated their growth kinetics, telomere length, karyotype, immunophenotype, and the differentiation potential during in vitro expansion. FLMSCs could be easily amplified in vitro with no significant shorting of telomere length and had a normal karyotype. No significant differences between passage 5 or passage 25 were observed in the immunophenotype analysis using flow cytometry. Moreover, flow cytometry results provided the first demonstration, to our knowledge, that FLMSCs stably expressed pluripotent markers including Oct4, Nanog, Sox2, TRA-1-60, c-Myc, and SSEA-4 through 25 passages. In vitro differentiation studies as identified by confocal microscopy, flow cytometry, RT-PCR, and immunohis-tochemistry showed that FLMSCs had extended capacity of differentiating into mesodermal, ectodermal, and endodermal lineages, and that their potential for adipogenic, osteogenic, and chondrogenic differentiation may be maintained over 25 passages. Furthermore, osteogenic and chondrogenic differentiation was used as an indicator of their differentiation capability in vivo, as evidenced by ectopic bone and cartilage formation. In summary, these results suggest that FLMSCs are a primitive population and that their extensive in vitro expansion does not involve significant functional modification of the cells, including morphology, growth, karyotype, immunophenotype, and mesodermal differentiation potential. Hence, FLMSCs might constitute an attractive cell resource for cell transplantation to induce regeneration of damaged tissues/organs.
机译:多能间充质基质细胞(MSCs)是用于细胞移植的有前途的细胞类型;然而,他们的利用仍然是有限的,直到有足够的替代来源的MSCs和彻底了解从各种来源隔离的MSC生物学的理解。胎儿肺已被确定为丰富的MSC来源。为了探讨传代胎儿肺MSCs(FLMSC)的治疗潜力,本研究评估了它们在体外膨胀期间的生长动力学,端粒长度,核型,免疫表型和分化电位。在体外可以容易地扩增FLMSCs,不能显着短缺细胞长度并且具有正常的核型。在使用流式细胞术中的免疫型分析中,在免疫表型分析中没有观察到通道5或通道25之间的显着差异。此外,流式细胞术研究结果提供了第一次演示,以我们的知识,FLMSCS稳定表达多能标记,包括OCT4,NANOG,SOX2,TRA-1-60,C-MYC和SSEA-4到25个通道。通过共聚焦显微镜,流式细胞术,RT-PCR和免疫ovis-转化鉴定的体外分化研究表明,FLMSCs的能力延长了中胚层,外胚层和内胚层谱系的能力,以及它们对脂肪生成,骨质发生和软骨形成分化的可能性可以保持超过25个段落。此外,骨质原性和软弱化分化被用作体内分化能力的指示剂,如异位骨和软骨形成所证明。总之,这些结果表明FLMSCS是原始群体,其广泛的体外膨胀不涉及细胞的显着功能改性,包括形态,生长,核型,免疫表型和中胚层分化潜力。因此,FLMSC可能构成细胞移植的有吸引力的细胞资源,以诱导受损组织/器官的再生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号